Last updated 2026-07-20
- Raised Pre-Seed round led by NGT HealthCare II, Apr 2023
Total raised
—
Last: Undisclosed Round 2023-05
Stage
Pre-Seed
Founded
2023
Headcount
4
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences
About
Emris Pharma is a preclinical stage company developing a first-in-class topical solution (SDT 011 / EMR-001) to prevent skin toxicities caused by EGFR inhibitor antibodies in cancer patients. This innovative solution aims to improve patients' quality of life and compliance with cancer treatment by blocking the anti-cancer drug at the toxicity site without interfering with the cancer treatment itself. The company's approach targets the initial mechanisms of toxicity, offering a novel way to prevent skin disorders during cancer treatment.
Funding history · 1 round · — total
2023-04
Pre-Seed
Undisclosed
★ NGT HealthCare IIIsrael Innovation Authority
Headcount over time
From 3 (2023-08) to 7 (2026-03) · +4 (+133%) · 7 points · source: Finder history + radar grounding
Q&A
- What is Emris Pharma's primary focus?
- Emris Pharma is developing a novel small molecule, topically administered, to prevent skin toxicities caused by EGFR inhibitors (EGFRi) in cancer patients.
- When was Emris Pharma founded?
- Emris Pharma was founded in May 2023.
- What is the current employee count at Emris Pharma?
- Emris Pharma has 6 employees, falling within the 1-10 employee bucket.
- Which investors participated in Emris Pharma's funding round in May 2023?
- In May 2023, Emris Pharma received funding from NGT HealthCare II and Israel Innovation Authority.
- What is the current stage of Emris Pharma's product development?
- Emris Pharma's product, SDT 011 (EMR-001), is currently in the R&D stage.
- What is Emris Pharma's primary sector?
- Emris Pharma's primary sector is Health Tech & Life Sciences.
- Does Emris Pharma hold any patents?
- Yes, Emris Pharma holds 1 patent.
Team · 3
Lyora Aharonov
Founder · CEO and Co-founder
Sharon Merims
Founder · CSO and Co-founder
Ofra Benny
Founder · CTO and Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
pharmaceuticalscancerskincancer-therapyskin-care
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | emris-pharma.com/ |
|---|---|
| linkedin.com/company/93267280 |
Identifiers & details
| Founded | 2023 |
|---|---|
| Employees (exact) | 4 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | emris-pharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516743176 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2023-01-11 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Active charges / liens | 0 |
| Registry events | 2 — violation (1), shares_capital (1) |
| Registered address | ואדי אל-חאג' 13 נצרת |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2026-06-11 | הקצאת מניות |